altered peptide ligands ligand - peptide-therapy-clinic-us Arginylglycylaspartic acid (RGD

x50-peptide Altered Peptide Ligands: Modulating Immune Responses Through Subtle Molecular Changes

Altered peptide ligands (APLs) represent a fascinating class of molecules that are peptide variants derived from original antigenic peptides.作者：PJ Fairchild·1997·被引用次数：18—Recent evidence has suggested, however, that subtle changes in the nature of theliganditself may also affect the outcome of T-cell receptor ( ... These subtle molecular changes, often involving specific amino acid substitutions, imbue APLs with the remarkable ability to modulate immune responses. By altering the structure of naturally occurring peptides, APLs can interact with the immune system in distinct ways, either downregulating or upregulating immune activity.作者：JE Park·2012·被引用次数：10—We have developed analtered peptide ligand of type II collagen, referred to as A9, which differentially regulates TCR signaling in murine T cells leading to ... This capacity for modulation makes them significant tools in the study and potential treatment of various immunological conditions, from autoimmune and allergic diseases to infectious diseases and cancer.作者：N Zoupanou·2024—Altered peptide ligands refer toamino acid modificationsof either those used to bind into pockets within the major histocompatibility complex (MHC) or of ... Understanding how these altered structures influence T-cell signaling and broader immune system dynamics is crucial for harnessing their therapeutic potential1996年4月1日—Altered peptide ligandscan induce a qualitatively different pattern of signal transduction eventsthan does any concentration of the native ligand..

The Mechanism of Action: How APLs Interact with the Immune System

The core function of altered peptide ligands lies in their interaction with the T-cell receptor (TCR) complexAltered peptide ligands: Prospects for immune intervention .... While derived from known antigenic peptides, even minor amino acid modifications can lead to significant differences in how the APL binds to the Major Histocompatibility Complex (MHC) and subsequently engages with the TCR作者：PP Yachi·2006·被引用次数：201—Altered peptide ligands (APLs) arepeptide variants derived from the original antigenic peptide, with substitutions at particular residue(s). APLs can be .... This interaction can result in a qualitatively different pattern of signal transduction events compared to the native peptide ligand. Instead of eliciting a full activation response, APLs can sometimes act as partial agonists, inducing only a subset of the signaling pathways or even functioning as antagonistsAltered peptide ligands of myelin basic protein (MBP87–99 .... This ability to fine-tune T-cell responses is a key aspect of their immunomodulatory power.作者：R Hoppes·2014·被引用次数：68—Epitopes modified based on amino acid substitutionsare termed “altered peptide ligands” (APLs) (11). A well-known example of such an APL is the alanine to ...

APLs have been shown to interfere with the priming of T-cell responses, effectively narrowing the repertoire of cellular responses.作者：M Candia·2016·被引用次数：59—This review article summarizes how APLs were detected and first described, current concepts of how APLs modify T cellular signaling, which biological ... This interference can lead to immune deviation, where the immune system's response is shifted from one type to another, for instance, from a T helper 1 (Th1) to a T helper 2 (Th2) responseAltered peptide ligands induce delayed CD8-T cell receptor .... Such shifts are critical in managing conditions where an overactive or misdirected immune response is detrimental, such as in autoimmune diseases.Altered Peptide Ligand Antagonism: From Immune Evasion to ... The precise nature of the modification, including the specific amino acid residue changes, dictates the resulting immune outcome.Altered Peptide Ligands Impact the Diversity of ...

Therapeutic Applications and Prospects

The unique properties of altered peptide ligands have positioned them as promising candidates for immunotherapeutic interventions.作者：N Zoupanou·2024—Altered peptide ligands refer toamino acid modificationsof either those used to bind into pockets within the major histocompatibility complex (MHC) or of ... Their capacity to modulate immune responses has been explored extensively in the context of autoimmune diseases like multiple sclerosis (MS). APLs derived from myelin basic protein peptide, for example, have been investigated for their potential to induce immune tolerance or shift the immune response away from self-tissue damage. Clinical trials have explored the efficacy of APLs in MS, with some studies indicating a lack of substantial improvement or worsening in certain patient cohorts, highlighting the complexity and nuanced nature of their application.

Beyond autoimmune disorders, APLs hold potential in cancer immunotherapy and the management of infectious diseases. By modifying the presentation of tumor-specific antigens or pathogen-derived epitopes, APLs could be engineered to stimulate anti-tumor immunity or modulate the immune response to pathogens. The concept of using APLs in vaccine design is also gaining traction, aiming to create vaccines that elicit specific, controlled immune responses rather than broad, potentially harmful ones.Molecular Mimicry in Multiple Sclerosis

Challenges and Future Directions

Despite their therapeutic promise, the development and application of altered peptide ligands are not without challenges作者：J Sloan-Lancaster·1995·被引用次数：92—Investigations of T-cell responses toaltered peptide ligandshave provided functional evidence that a T-cell receptor can interpret subtle structural changes .... The precise prediction of how specific amino acid substitutions will affect TCR signaling and the overall immune response remains a complex area of research.作者：M Candia·2016·被引用次数：59—This review article summarizes how APLs were detected and first described, current concepts of how APLs modify T cellular signaling, which biological ... Subtle changes can lead to vastly different outcomes, and off-target effects or unexpected immune reactions are potential concerns作者：JE Park·2012·被引用次数：10—We have developed analtered peptide ligand of type II collagen, referred to as A9, which differentially regulates TCR signaling in murine T cells leading to .... Furthermore, the development of APLs requires a deep understanding of the specific immunological context of the disease being targeted.

Future research will likely focus on refining our understanding of the structure-function relationships of APLs, developing more precise methods for predicting their immunomodulatory effects, and optimizing their delivery and formulation for therapeutic use. Advancements in molecular biology and immunology continue to shed light on the intricate mechanisms by which these altered peptide ligands interact with the immune system, paving the way for more targeted and effective immunotherapies. The journey of altered peptide ligands from laboratory discovery to clinical application is a testament to the power of subtle molecular modifications in orchestrating complex biological processes.